Karen Knudsen/LinkedIn
May 7, 2025, 08:32
Karen Knudsen: The Future of Science and Medical Innovation Depends on Bold Funding of High Impact Discoveries
Karen Knudsen, CEO of Parker Institute for Cancer Immunotherapy, shared a post on LinkedIn:
“The future of science and medical innovation depends on how we fund high impact discoveries …and who’s willing to go first.
Today Milken Institute Global, I’ll join visionary leaders across multiple sectors to explore how public-private partnerships can accelerate progress in medicine and health.
At the Parker Institute for Cancer Immunotherapy (PICI), we’re not waiting for change. We are building it! From pioneering discoveries to launching companies, PICI is designed to move science forward, faster.
Really looking forward to discussing new and different ways to partner, so that we continue to make progress against cancer.”
More posts featuring Karen Knudsen on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 7, 2025, 09:13
May 7, 2025, 08:50
May 7, 2025, 08:47